Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement

Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement

Submitted by admin on September 18, 2023 - 12:30pm
Source: 
Fierce Pharma
News Tags: 
Samsung BioLogics
Bristol Myers Squibb
drug manufacturing
antibodies
Headline: 
Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement
snippet: 

After inking and expanding a biosimilar production partnership with Pfizer this summer, Korea’s Samsung Biologics is boosting yet another Big Pharma manufacturing agreement.

Do Not Allow Advertisers to Use My Personal information